Page History
Request | Notes | Status | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Update Examples from TB-TAUG. | Remodel this assay and data in IS. Fix modeling mistakes in the TB TAUG Also requested by Joleen White |
| |||||||||
| See his feedback in the comment section. 2023-09-07: We are not going to update the example | as well. Questions about specimen info in this example.See his feedback in the comment section. We will clarify in the example description that: ISCNDAGT is NOT controlled so this could be ESAT-6, CFP-10 or other peptide (instead of TB1 and TB2 Antigens). We are not suggesting that the stimulating agents used for TB IFN-y test have to be TB1/2 Antigens. This is just an example to show which variable needs to be used to populate which type of data, in order to make a meaningful and unique record. It is up to the sponsor to decide what collected value should be mapped to ISCNDAGT. |
| ||||||||
|
|
...
Jordan Li When moving this example to the Example Collection for internal and public review, update the example description to mention that: ISCNDAGT is NOT controlled so this could be ESAT-6, CFP-10 or other peptide (instead of TB1 and TB2 Antigens). We are not suggesting that the stimulating agents used for TB study IFN-y test have to be TB1/2 Antigens. This is just an example to show which variable needs to be used to populate which type of data, in order to make a meaningful and unique record. It is up to the sponsor to decide what collected value should be mapped to ISCNDAGT.
...